Pyxis Oncology, Inc.
PYXS
$1.70
$0.010.59%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | 17.71% | -19.88% | 13.25% | 40.52% |
| Total Depreciation and Amortization | -- | 449.72% | -1.50% | -3.08% | 0.36% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -29.99% | 18.53% | -12.97% | -88.09% |
| Change in Net Operating Assets | -- | -47.58% | 408.67% | 61.60% | 30.98% |
| Cash from Operations | -- | 21.47% | 23.09% | 23.39% | -16.82% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 41.65% | -24.99% | -3.27% | -40.65% |
| Cash from Investing | -- | 41.76% | -25.05% | -3.27% | -40.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -787.50% | 88.06% | -3,250.00% | 99.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 8,462.50% | 88.06% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 458.49% | 10.46% | 69.82% | -190.52% |